The initial optimism surrounding precision medicine, with the completion of the Human Genome Project, is now facing scrutiny. The complexity of diseases, often influenced by multiple genes, has raised questions about whether too much emphasis has been placed on genetics. Critics argue that focusing on environmental and lifestyle factors may be more effective in tackling common diseases. However, precision medicine has shown promise in treating certain cancers, coronary artery disease, and rare genetic conditions. Its public health impact remains limited, and the balance between genetics and other factors in healthcare decision-making continues to be debated.
Do you believe precision medicine has lived up to its initial promise, or should more attention be given to preventive measures and public health interventions?